Brian Rah, MD
Interventional Cardiology · Billings, MTNPI 1518995158
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 68.7% of it on its own, with 4 other manufacturers making up the rest. That places this record below the midpoint for interventional cardiology clinicians in MT, where the typical reported total is $5,910.
Across 22 payments — averaging $36.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$553
- Edwards Lifesciences$128
- Abiomed$50
- Abbott$45
- Shockwave Medical, Inc$29
What the payments were for
- Food & beverage$805100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $553 |
| Edwards Lifesciences | 2 | $128 |
| Abiomed | 2 | $50 |
| Abbott | 2 | $45 |
| Shockwave Medical, Inc | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$805 in reported general payments places this provider in the 15th percentile of 22 interventional cardiology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 145 | $160,487 |
| Repatha SureclickEvolocumab | 88 | $108,313 |
| Praluent PenAlirocumab | 22 | $24,512 |
| XareltoRivaroxaban | 16 | $18,215 |
| FarxigaDapagliflozin Propanediol | 14 | $13,806 |
| Metoprolol Succinate | 271 | $3,689 |
| Repatha SyringeEvolocumab | 11 | $3,586 |
| Atorvastatin Calcium | 367 | $3,263 |
| Potassium Chloride | 34 | $1,313 |
| Lisinopril | 197 | $1,179 |
| Losartan Potassium | 149 | $1,131 |
| Carvedilol | 117 | $902 |
| Metoprolol Tartrate | 135 | $832 |
| Rosuvastatin Calcium | 84 | $665 |
| Ezetimibe | 33 | $636 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Billings
- Robert MinorBillings$46K
- Claudia Lama von BuchwaldBillings$29K
- Per SommerBillings$27K
- Robert TerryBillings$12K
- Ronald HenckelBillings$6K
- Shunsuke AoiBillings$3K
- Cindy TomBillings$80
- Steven GoldbergGreat Falls$134K
- Daniel SpoonMissoula$58K
- Michael EisenhauerGreat Falls$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.